Schroders Capital logo

Schroders Capital

Europe, England, United Kingdom, London

Description

Schroders Capital helps the clients with the management of the investments.

Investor Profile

Schroders Capital has made 26 investments, with 8 in the past 12 months and 23% as lead.

Stage Focus

  • Series C (23%)
  • Debt Financing (15%)
  • Series A (15%)
  • Series B (15%)
  • Series Unknown (12%)
  • Series D (4%)
  • Series E (4%)
  • Seed (4%)
  • Post Ipo Equity (4%)
  • Post Ipo Debt (4%)

Country Focus

  • United States (27%)
  • United Kingdom (27%)
  • Switzerland (19%)
  • The Netherlands (12%)
  • France (4%)
  • India (4%)
  • Canada (4%)
  • Luxembourg (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Renewable Energy
  • Pharmaceutical
  • Elder Care
  • Home Health Care
  • Mobile Apps
  • Outpatient Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Schroders Capital frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 3
Inovia Capital
North America, Quebec, Canada, Montréal
Co-Investments: 2
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 3
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Pureos Bioventures
Europe, Zurich, Switzerland, Küsnacht
Co-Investments: 3
The Column Group
North America, California, United States, San Francisco
Co-Investments: 3
redalpine
Europe, Zurich, Switzerland, Zürich
Co-Investments: 2
Mirae Asset
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2

Which angels does Schroders Capital often collaborate with?

DV
Europe, Zuid-Holland, The Netherlands, Rotterdam
Shared Deals: 1
ES
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
RK
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Schroders Capital?

Azafaros

Leiden, Zuid-Holland, The Netherlands

Azafaros aims at developing new therapeutic agents for the treatment of rare metabolic disorders.

BiotechnologyHealth CareTherapeutics
Series BMay 13, 2025
Amount Raised: $146,690,300
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.

BiotechnologyGeneticsHealth CareMedicalTherapeutics
Series AMay 8, 2025
Amount Raised: $65,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Luminance

Cambridge, Cambridgeshire, United Kingdom

Luminance provides an AI-powered platform for contract generation, negotiation, and post-execution analysis using legal-focused models.

Artificial Intelligence (AI)Contact ManagementLegalLegal Tech
Series CFeb 18, 2025
Amount Raised: $75,000,000
Cera

London, England, United Kingdom

Cera is Europe’s largest provider of digital-first home healthcare

Artificial Intelligence (AI)Elder CareHealth CareHome Health CareMobile AppsOutpatient CarePersonal HealthPredictive Analytics
Debt FinancingJan 12, 2025
Amount Raised: $150,000,000
Cera

London, England, United Kingdom

Cera is Europe’s largest provider of digital-first home healthcare

Artificial Intelligence (AI)Elder CareHealth CareHome Health CareMobile AppsOutpatient CarePersonal HealthPredictive Analytics
Series UnknownJan 12, 2025
Somagenetix

Zürich, Zurich, Switzerland

Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses.

Pharmaceutical
Series AOct 8, 2024
Amount Raised: $11,663,277
Poolside

San Francisco, California, United States

Poolside is an artificial intelligence platform that offers foundation concepts and infrastructure to write software codes.

Artificial Intelligence (AI)Developer PlatformInformation TechnologyInfrastructureSoftware
Series BOct 2, 2024
Amount Raised: $500,000,000
Enfinity Global

Miami, Florida, United States

Enfinity Global is a renewable energy company that focuses on developing, financing, and operating solar energy and energy storage projects.

EnergyRenewable EnergySolar
Debt FinancingAug 27, 2024
Amount Raised: $558,832,799
iOnctura

Genève, Geneve, Switzerland

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

BiotechnologyHealth CareMedical DevicePharmaceutical
Series BJun 20, 2024
Amount Raised: $85,897,462